Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greensboro, NC
NPI
1093890287
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1511 Westover Ter, Suite 201
Greensboro, NC, 27408
Phone (336) 533-4192
Groups this clinician bills Medicare through
Medicare paid, 2024
$116K
4,121 services
Medicare patients, 2024
317
Average age 74
Drug cost, 2024
$2.8M
9,475 prescriptions
Company payments, 2025
$381
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bindubal Balan was code J0897 (injection, denosumab, 1 mg), 3,300 times for 34 patients. In total Bindubal Balan billed 4,121 services in 16 codes, and Medicare paid $116K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,300 | 34 | $20.46 | $68K |
| 99214 Office E&M - Established | Office | 384 | 231 | $81.28 | $31K |
| 99213 Office E&M - Established | Office | 106 | 85 | $60.92 | $6,457 |
| 95251 Test - Miscellaneous | Office | 94 | 50 | $25.00 | $2,350 |
| 96372 Injection Administration | Office | 56 | 35 | $10.63 | $595 |
| 83036 Blood Count | Office | 42 | 42 | $9.52 | $400 |
| 99204 Office E&M - New | Office | 31 | 31 | $102.48 | $3,177 |
| G0008 Administration of influenza virus vaccine | Office | 22 | 22 | $30.39 | $669 |
| 90673 Vaccine Product | Office | 22 | 22 | $81.82 | $1,800 |
| 77080 Standard X-ray | Office | 14 | 14 | $35.53 | $497 |
| 99203 Office E&M - New | Office | 11 | 11 | $63.60 | $700 |
By year: 2022 $88K for 3,497 services; 2023 $100K for 3,602 services; 2024 $116K for 4,121 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 42 | 42 | $9.52 | $400 |
Medicare prescription drug claims, 2024
In 2024, the drug Bindubal Balan prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,864 prescriptions and refills. In total Bindubal Balan wrote 9,475 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,864 | 4,243 | 403 | $16K |
| Mounjaro Tirzepatide | 482 | 565 | 88 | $588K |
| Synthroid Levothyroxine Sodium | 414 | 801 | 73 | $29K |
| Metformin Hcl Er Metformin Hcl | 369 | 789 | 89 | $4,057 |
| Jardiance Empagliflozin | 357 | 485 | 62 | $282K |
| Tresiba Flextouch U-100 Insulin Degludec | 300 | 494 | 58 | $178K |
| Rosuvastatin Calcium Generic | 222 | 626 | 66 | $2,889 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 202 | 457 | 69 | $21K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 184 | 302 | 46 | $27K |
| Tradjenta Linagliptin | 151 | 184 | 26 | $93K |
| Ozempic Semaglutide | 150 | 193 | 38 | $175K |
| Glimepiride Generic | 149 | 376 | 44 | $2,512 |
| Novolog Flexpen Insulin Aspart | 130 | 213 | 37 | $31K |
| Amlodipine Besylate Generic | 127 | 289 | 31 | $545 |
| Januvia Sitagliptin Phosphate | 126 | 169 | 26 | $92K |
Brand drugs: 4,762 claims; generic drugs: 3,984 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bindubal Balan $381 ($381 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $210.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.